| Name | 3-hydroxy-3-methylglutaryl-CoA reductase |
| Description | HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nHMG‐CoA reductase (HMGCR) is the highly conserved, endoplasmic reticulum–bound rate‐limiting enzyme in cholesterol and isoprenoid biosynthesis. It is subject to elaborate regulation at multiple levels – transcriptional, translational, post‐translational, and via targeted degradation. Sterol intermediates such as lanosterol and its derivatives and oxygen–responsive factors (e.g. HIF‑1α) help trigger HMGCR ubiquitination through interactions with Insig proteins and E3 ligases (for example, gp78 and MARCH6), thereby fine–tuning enzyme abundance and cholesterol flux. These feedback mechanisms have been reconstituted in both in vitro and in vivo models and reveal that subtle changes in intracellular sterol levels (mediated by exogenous sterols, mevalonate, or natural compounds) directly control HMGCR stability and catalytic activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its central biochemical role, HMGCR is the primary target of statins—the most widely prescribed cholesterol‐lowering drugs. Variability in statin response has been linked to common single–nucleotide polymorphisms, alternative splicing events (including exon 13 skipping regulated by RNA–binding factors such as HNRNPA1), and differences in promoter architecture; these genetic factors affect both enzyme expression and sensitivity to inhibition, and they contribute to inter–individual differences in low–density lipoprotein cholesterol reduction, cardiovascular disease risk, and even the development of statin–associated side effects such as immune–mediated necrotizing myopathy and new–onset diabetes. Moreover, integrated genetic and Mendelian randomization studies have underscored that life–long modulation of HMGCR activity influences not only lipid levels but also risk for Alzheimer’s disease and other neurologic conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "28"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_fs", "start_ref": "29", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent studies have also implicated aberrant HMGCR expression and regulation in a wide range of pathophysiological contexts beyond atherosclerosis. Increased HMGCR activity has been documented in settings of viral infection, as during dengue virus–induced cholesterol accumulation, and in metabolic disorders such as non–alcoholic fatty liver disease where microRNA dysregulation alters HMGCR expression. In cancer, elevated HMGCR not only confers resistance to statin therapy in several breast and ovarian cancer models but can also promote tumorigenesis by modulating oncogenic pathways (for example, via MYC phosphorylation or activation of Hedgehog/Gli1 signaling). Furthermore, mutations in proteins interacting with HMGCR—such as UBIAD1 in Schnyder corneal dystrophy—can impair its regulated degradation. Finally, natural compounds with “statin–like” properties have been shown to inhibit HMGCR activity, underscoring its promise as a therapeutic target in chemoprevention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "34", "end_ref": "46"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "L M Rasmussen, P R Hansen, M T Nabipour, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/0264-6021:3600363"}], "href": "https://doi.org/10.1042/0264-6021:3600363"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11716764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11716764"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mats Rudling, Bo Angelin, Lars Ståhle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2002-012041"}], "href": "https://doi.org/10.1210/jc.2002-012041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12213890"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12213890"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sander M Houten, Marit S Schneiders, Ronald J A Wanders, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M206564200"}], "href": "https://doi.org/10.1074/jbc.M206564200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12477733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12477733"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Bao-Liang Song, Russell A DeBose-Boyd "}, {"type": "b", "children": [{"type": "t", "text": "Ubiquitination of 3-hydroxy-3-methylglutaryl-CoA reductase in permeabilized cells mediated by cytosolic E1 and a putative membrane-bound ubiquitin ligase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M402442200"}], "href": "https://doi.org/10.1074/jbc.M402442200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15090540"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15090540"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Bao-Liang Song, Norman B Javitt, Russell A DeBose-Boyd "}, {"type": "b", "children": [{"type": "t", "text": "Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2005.01.001"}], "href": "https://doi.org/10.1016/j.cmet.2005.01.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16054061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16054061"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Valentina Pallottini, Barbara Guantario, Chiara Martini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of HMG-CoA reductase expression by hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.21757"}], "href": "https://doi.org/10.1002/jcb.21757"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18459144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18459144"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "John S Burg, Peter J Espenshade "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of HMG-CoA reductase in mammals and yeast."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prog Lipid Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.plipres.2011.07.002"}], "href": "https://doi.org/10.1016/j.plipres.2011.07.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21801748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21801748"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Sung-Yun Cho, Hee-jin Jun, Ji Hae Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linalool reduces the expression of 3-hydroxy-3-methylglutaryl CoA reductase via sterol regulatory element binding protein-2- and ubiquitin-dependent mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2011.09.012"}], "href": "https://doi.org/10.1016/j.febslet.2011.09.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21944868"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21944868"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Noam Zelcer, Laura J Sharpe, Anke Loregger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01140-13"}], "href": "https://doi.org/10.1128/MCB.01140-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24449766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24449766"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Seonghwan Hwang, Andrew D Nguyen, Youngah Jo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-inducible factor 1α activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M117.788562"}], "href": "https://doi.org/10.1074/jbc.M117.788562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28416613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28416613"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Liang Chen, Mei-Yan Ma, Ming Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.RA119000201"}], "href": "https://doi.org/10.1194/jlr.RA119000201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31455613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31455613"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Daniel I Chasman, David Posada, Lakshman Subrahmanyan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacogenetic study of statin therapy and cholesterol reduction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jama.291.23.2821"}], "href": "https://doi.org/10.1001/jama.291.23.2821"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15199031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15199031"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Federico Licastro, Elisa Porcellini, Calogero Caruso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2006.07.007"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2006.07.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16930778"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16930778"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "K M Steffen, M E Cooper, M Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Perinatol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.jp.7211806"}], "href": "https://doi.org/10.1038/sj.jp.7211806"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17855807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17855807"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yvonne Lange, Daniel S Ory, Jin Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M706967200"}], "href": "https://doi.org/10.1074/jbc.M706967200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18024962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18024962"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Eliana Polisecki, Hind Muallem, Nobuyo Maeda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.atherosclerosis.2007.12.004"}], "href": "https://doi.org/10.1016/j.atherosclerosis.2007.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18261733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18261733"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ronald M Krauss, Lara M Mangravite, Joshua D Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.107.708388"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.107.708388"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18332269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18332269"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sekar Kathiresan, Olle Melander, Dragi Anevski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms associated with cholesterol and risk of cardiovascular events."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa0706728"}], "href": "https://doi.org/10.1056/NEJMoa0706728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18354102"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18354102"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Ralph Burkhardt, Eimear E Kenny, Jennifer K Lowe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.108.172288"}], "href": "https://doi.org/10.1161/ATVBAHA.108.172288"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18802019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18802019"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Louise A Donnelly, Alex S F Doney, Jennifer Dannfald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e3283106071"}], "href": "https://doi.org/10.1097/FPC.0b013e3283106071"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18815589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18815589"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Rahul C Deo, David Reich, Arti Tandon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1000342"}], "href": "https://doi.org/10.1371/journal.pgen.1000342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19148283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19148283"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "John F Thompson, Craig L Hyde, Linda S Wood, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Cardiovasc Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCGENETICS.108.818062"}], "href": "https://doi.org/10.1161/CIRCGENETICS.108.818062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20031582"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20031582"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Mary E Keebler, Christopher L Sanders, Aarti Surti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of blood lipids with common DNA sequence variants at 19 genetic loci in the multiethnic United States National Health and Nutrition Examination Survey III."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Cardiovasc Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCGENETICS.108.829473"}], "href": "https://doi.org/10.1161/CIRCGENETICS.108.829473"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20031591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20031591"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Lara M Mangravite, Marisa Wong Medina, Jinrui Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.110.203273"}], "href": "https://doi.org/10.1161/ATVBAHA.110.203273"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20413733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20413733"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Zhongwei Cao, Hua Fan-Minogue, David I Bellovin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-3367"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-3367"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21262914"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21262914"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Youngah Jo, Peter V Sguigna, Russell A DeBose-Boyd "}, {"type": "b", "children": [{"type": "t", "text": "Membrane-associated ubiquitin ligase complex containing gp78 mediates sterol-accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.211326"}], "href": "https://doi.org/10.1074/jbc.M110.211326"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21343306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21343306"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Andrew L Mammen, Tae Chung, Lisa Christopher-Stine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Rheum (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/art.30156"}], "href": "https://doi.org/10.1002/art.30156"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21360500"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21360500"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Chi-Yi Yu, Elizabeth Theusch, Kathleen Lo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddt422"}], "href": "https://doi.org/10.1093/hmg/ddt422"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24001602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24001602"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Daniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0140-6736(14)61183-1"}], "href": "https://doi.org/10.1016/S0140-6736(14"}, {"type": "t", "text": "61183-1) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25262344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25262344"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Vicky Howe, Laura J Sharpe, Anika V Prabhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New insights into cellular cholesterol acquisition: promoter analysis of human HMGCR and SQLE, two key control enzymes in cholesterol synthesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Cell Biol Lipids (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbalip.2017.03.009"}], "href": "https://doi.org/10.1016/j.bbalip.2017.03.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28342963"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28342963"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Marianne Benn, Børge G Nordestgaard, Ruth Frikke-Schmidt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low LDL cholesterol, "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "PCSK9"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "HMGCR"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMJ (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/bmj.j1648"}], "href": "https://doi.org/10.1136/bmj.j1648"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28438747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28438747"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Brian A Ference, John J P Kastelein, Henry N Ginsberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jama.2017.11467"}], "href": "https://doi.org/10.1001/jama.2017.11467"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28846118"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28846118"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Payam Mohassel, Océane Landon-Cardinal, A Reghan Foley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurol Neuroimmunol Neuroinflamm (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/NXI.0000000000000523"}], "href": "https://doi.org/10.1212/NXI.0000000000000523"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30588482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30588482"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Youngah Jo, Isamu Z Hartman, Russell A DeBose-Boyd "}, {"type": "b", "children": [{"type": "t", "text": "Ancient ubiquitous protein-1 mediates sterol-induced ubiquitination of 3-hydroxy-3-methylglutaryl CoA reductase in lipid droplet-associated endoplasmic reticulum membranes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E12-07-0564"}], "href": "https://doi.org/10.1091/mbc.E12-07-0564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23223569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23223569"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Rubén Soto-Acosta, Clemente Mosso, Margot Cervantes-Salazar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.virol.2013.04.003"}], "href": "https://doi.org/10.1016/j.virol.2013.04.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23642566"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23642566"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Ping Peng, Lu Wang, Xi Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0102265"}], "href": "https://doi.org/10.1371/journal.pone.0102265"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25084356"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25084356"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Chuanzheng Sun, Feizhou Huang, Xunyang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2015.2076"}], "href": "https://doi.org/10.3892/ijmm.2015.2076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25605429"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25605429"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Marc M Schumacher, Rania Elsabrouty, Joachim Seemann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.05560"}], "href": "https://doi.org/10.7554/eLife.05560"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25742604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25742604"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Brian A Ference, Faisal Majeed, Raju Penumetcha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Coll Cardiol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jacc.2015.02.020"}], "href": "https://doi.org/10.1016/j.jacc.2015.02.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25770315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25770315"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Shudong Liu, Fei Jing, Chunxiao Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0124951"}], "href": "https://doi.org/10.1371/journal.pone.0124951"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25933205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25933205"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Jessica E Stine, Hui Guo, Xiugui Sheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5834"}], "href": "https://doi.org/10.18632/oncotarget.5834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26503475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26503475"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Li Chushi, Wu Wei, Xie Kangkang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2016.04.029"}], "href": "https://doi.org/10.1016/j.gene.2016.04.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27085483"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27085483"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Brian A Ference, Jennifer G Robinson, Robert D Brook, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa1604304"}], "href": "https://doi.org/10.1056/NEJMoa1604304"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27959767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27959767"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Marco Fiorillo, Maria Peiris-Pagès, Rosa Sanchez-Alvarez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Bioenerg (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbabio.2018.03.018"}], "href": "https://doi.org/10.1016/j.bbabio.2018.03.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29626418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29626418"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Andy Göbel, Dorit Breining, Martina Rauner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-1322-x"}], "href": "https://doi.org/10.1038/s41419-019-1322-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30692522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30692522"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "James Yarmolinsky, Caroline J Bull, Emma E Vincent, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jama.2020.0150"}], "href": "https://doi.org/10.1001/jama.2020.0150"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32068819"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32068819"}]}]}]}
|
| Synonyms | LDLCQ3 |
| Proteins | HMDH_HUMAN |
| NCBI Gene ID | 3156 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
HMGCR has 15,146 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 133 datasets.
Click the + buttons to view associations for HMGCR from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of HMGCR gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of HMGCR gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of HMGCR gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of HMGCR gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of HMGCR gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of HMGCR gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of HMGCR gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of HMGCR gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of HMGCR gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of HMGCR gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of HMGCR gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of HMGCR gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with HMGCR protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with HMGCR gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of HMGCR gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of HMGCR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of HMGCR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of HMGCR gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing HMGCR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing HMGCR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with HMGCR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with HMGCR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with HMGCR gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with HMGCR gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with HMGCR gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with HMGCR gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of HMGCR protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving HMGCR gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with HMGCR gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with HMGCR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with HMGCR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with HMGCR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with HMGCR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for HMGCR protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at HMGCR gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of HMGCR gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of HMGCR gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing HMGCR from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with HMGCR gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with HMGCR gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of HMGCR gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with HMGCR gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing HMGCR from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of HMGCR gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of HMGCR gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of HMGCR gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of HMGCR gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of HMGCR gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of HMGCR gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding HMGCR protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving HMGCR gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving HMGCR gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving HMGCR gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing HMGCR protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing HMGCR protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing HMGCR protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by HMGCR gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by HMGCR gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by HMGCR gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of HMGCR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of HMGCR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of HMGCR gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of HMGCR gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding HMGCR receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with HMGCR gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with HMGCR gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with HMGCR gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with HMGCR gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of HMGCR gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for HMGCR protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of HMGCR gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of HMGCR gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of HMGCR protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of HMGCR gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for HMGCR from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with HMGCR gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| HumanCyc Pathways | pathways involving HMGCR protein from the HumanCyc Pathways dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for HMGCR protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of HMGCR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of HMGCR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of HMGCR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate HMGCR protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving HMGCR protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving HMGCR protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate HMGCR protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of HMGCR gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of HMGCR gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with HMGCR gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of HMGCR gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of HMGCR gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of HMGCR gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of HMGCR gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing HMGCR protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain HMGCR protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by HMGCR gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting HMGCR gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of HMGCR gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by HMGCR gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of HMGCR gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for HMGCR protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of HMGCR gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with HMGCR gene from the curated OMIM Gene-Disease Associations dataset. | |
| PANTHER Pathways | pathways involving HMGCR protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for HMGCR from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of HMGCR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of HMGCR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving HMGCR protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving HMGCR protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with HMGCR protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| Reactome Pathways 2014 | pathways involving HMGCR protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving HMGCR protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of HMGCR gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of HMGCR gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of HMGCR gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of HMGCR gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at HMGCR gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of HMGCR gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of HMGCR gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with HMGCR protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of HMGCR gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of HMGCR gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of HMGCR gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of HMGCR gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of HMGCR gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of HMGCR gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of HMGCR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of HMGCR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of HMGCR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of HMGCR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with HMGCR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with HMGCR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving HMGCR protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving HMGCR protein from the WikiPathways Pathways 2024 dataset. | |